Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
Sales | 5,576 | 5,306 | 8,077 | 6,589 | 5,594 |
Cost of Goods | 1,598 | 1,673 | 2,797 | 1,615 | 1,478 |
Gross Profit | 3,978 | 3,633 | 5,280 | 4,974 | 4,116 |
Operating Expenses | 10,096 | 10,229 | 11,762 | 11,525 | 11,019 |
Operating Income | -5,520 | -5,923 | -5,685 | -5,936 | -6,425 |
Other Income | 328 | 423 | 534 | 616 | 809 |
Pre-tax Income | -5,192 | -5,500 | -5,151 | -5,320 | -5,616 |
Net Income Continuous | -5,192 | -5,500 | -5,151 | -5,320 | -5,616 |
Net Income | $-5,192 | $-5,500 | $-5,151 | $-5,320 | $-5,616 |
EPS Basic Total Ops | -0.25 | -0.26 | -0.25 | -0.25 | -0.27 |
EPS Basic Continuous Ops | -0.25 | -0.26 | -0.25 | -0.25 | -0.27 |
EPS Diluted Total Ops | -0.25 | -0.26 | -0.25 | -0.25 | -0.27 |
EPS Diluted Continuous Ops | -0.25 | -0.26 | -0.25 | -0.25 | -0.27 |
EBITDA(a) | $-5,025 | $-5,426 | $-5,322 | $-5,471 | $-5,952 |